[New frontieres of treatment in oncology].
Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT, USA.
R
R
Canetta
D006801:Humans; D009369:Neoplasms / Q000378:metabolism / Q000628:therapy*